DMARDs for RA Improve Vascular Inflammation and CV Risk DMARDs for RA Improve Vascular Inflammation and CV Risk

Receipt of a tumor necrosis factor inhibitor or triple therapy for rheumatoid arthritis yielded an equally beneficial effect for reducing vascular inflammation and cardiovascular risk.Medscape Medical News
Source: Medscape Rheumatology Headlines - Category: Rheumatology Tags: Rheumatology News Source Type: news